| BAEKDU | HANRA 1 | HANRA 2 | HANRA 3 | BAEKJE | Lobby | |
|---|---|---|---|---|---|---|
| 08:40-09:00 | Opening Ceremony | 10:00~18:30Poster Session | ||||
| 09:00-10:15 | Scientific Symposium 1 Current status of precision medicine in oncology area |
Scientific Symposium 2 IT biotech & digital health in oncology |
Scientific Symposium 3 Immunotherapy: Emerging strategies for combination of immune checkpoint modulators |
Scientific Symposium 4 State of the art on systemic therapy in HCC |
||
| 10:15-10:30 | Break | |||||
| 10:30-11:10 | Plenary Lecture 1 Targeting DNA repair in Breast Cancer Andrew Tutt (The Institute of Cancer Research, UK) |
|||||
| 11:10-11:50 | Presidential Sympsoium The VHL tumor suppressor gene: Insights into oxygen sensing and cancer William G. Kaelin, Jr. (Dana-Farber Cancer Institute, USA) |
|||||
| 11:50-12:30 | Luncheon Symposium 1 New Horizon of Neoadjuvant and Adjuvant Treatment in HER2-positive Breast Cancer |
Luncheon Symposium 2 New perspectives for the future treatment option in non small cell lung cancer |
Satellite Symposium 1 How can we improve the outcome of pancreatic cancer? |
|||
| 12:30-12:50 | Break | |||||
| 12:50-13:50 | Special Symposium Research, write, publish |
Oral Presentation 1 |
Oral Presentation 2 |
Multidisciplinary Oncology Team Education Session 1 Immuno-oncologic therapy and pharmacologic management KOR |
Oral Presentation 3 |
|
| 13:50-14:10 | Break | |||||
| 14:10-15:40 | ASCO/KSMO Joint Symposium 1 Utilization of NGS to improve patient care |
Scientific Symposium 5 Modulating microenvironment for cancer treatment |
KOSRO/KSMO Joint Symposium The promise of combining RT and immunotherapy |
Multidisciplinary Oncology Team Education Session 2 Oncology nursing care in immune-oncology and targeted agent KOR |
||
| 15:40-16:00 | Break | |||||
| 16:00-17:30 | ASCO/KSMO Joint Symposium 2 Integrated platform for precision medicine |
Scientific Symposium 6 Translational Research - Biomarker studies to achieve desired clinical applications |
Scientific Symposium 7 GY cancer multimodality treatment |
|||
| 17:30-18:30 | Satellite Symposium 2 Changing the trajectory for patients with breast cancer |
Satellite Symposium 3 Emerging targeted treatment for rare lung cancer |
Satellite Symposium 4 Mapping post-progression treatment options for patients with advanced GC or mCRC |
Satellite Symposium 5 Optimal management of BTcP (Breakthrough cancer pain) |
Satellite Symposium 6 Navigating a new therapeutic era for Immune-oncology | |
| BAEKDU 1 | BAEKDU 2 | BAEKDU 3 | BAEKJE | Lobby | |
|---|---|---|---|---|---|
| 08:00-08:50 | Satellite Symposium 7  Optimizing clinical application of new targeted agents in HCC |
Satellite Symposium 8 New indication of immune-check point inhibitor PDL-1 antibody |
Satellite Symposium 9 Metastatic cancers and bone health management |
Satellite Symposium 10 New Insights and Clinical Implications for the Treatment of ALK+NSCLC |
09:00~17:00 Poster Session |
| 09:00-10:30 | Scientific Symposium 8 Partnering between biotechs and investigators in early phase drug development |
Scientific Symposium 9 Precision oncology and cancer epigenetics |
KCSG/KSMO Joint Symposium Awareness and Understanding of Toxicities from Immunotherapy |
Oral Presentation 4 |
|
| 10:30-10:50 | Break | ||||
| 10:50-11:30 | Plenary Lecture 2 Past, present and future of geriatric oncology Hans Wildiers (University Hospitals Leuven, Belgium) |
||||
| 11:30-12:10 | Noe Kyeong Kim Memorial Award & Lecture | ||||
| 12:10-12:50 | Luncheon Symposium 3 The new era of advanced NSCLC treatment: Time to navigate patient journey with optimal front-line treatment |
Satellite Symposium 11 What is being considered for continuum of care in metastatic colorectal cancer? |
|||
| 12:50-13:10 | Break | ||||
| 13:10-13:50 | Plenary Lecture 3 The reality versus potential of immune check-point inhibitors as cancer therapeutics Heather Wakelee (Stanford University, USA) |
||||
| 13:50-14:00 | Break | ||||
| 14:00-15:30 | JSMO/KSMO Joint Symposium Clinical trials in Asia: opportunities and challenges |
Scientific Symposium 10 Geriatric oncology |
KSSO/KSMO Joint Symposium Evolving strategies for surgery and systemic therapy in the neoadjuvant treatment era |
Oral Presentation 5 |
|
| 15:30-15:50 | Break | ||||
| 15:50-17:20 | KSP/KSMO Joint Symposium Immune Biomarker |
Scientific Symposium 11 Radiomics: Primer for medical oncologists |
Oncology Multi-Disciplinary Symposium Discrepancy between clinical practice and regulation in Korea KOR |
Multidisciplinary Oncology Team Education Session 3 CRC/CRA in clinical trial of precision medicine KOR |
|
| 17:20-17:40 | Closing Ceremony | ||||
